FDA, Hims and Trump
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...
Here's what's taking off and landing in the world of Bay Area business this Tuesday morning. Don't be let down.
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans ...
Trump taps a Fox News personality, a surgeon and a former Congressman to lead public health agencies
Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken," vowing a shakeup. As part of a flurry of ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA. Makary served as the editor-in-chief ...
(NEW YORK) — President Donald Trump said he wants Marty Makary, a Johns Hopkins surgeon and author who argued against pandemic lockdowns, to lead the U.S. Food and Drug Administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback